Uploaded December 2025 | Updated September 2026, 2 weeks ago
A Heterodox Conversation™ with Dr. Michael Burns (biologist) and Dr. Joseph Vukov (philosopher) exploring one of the most urgent ethical questions of our time: When — if ever — is it morally permissible to genetically modify human embryos?
Hosted at SUNY Cortland, this session blends hard science with ethical reasoning as Burns and Vukov walk students through the biology of CRISPR, the realities of unintended genetic consequences, the risks of homogenizing the human gene pool, fairness and access, enhancement vs therapy, and the deeper moral questions about human dignity and treating future children as products.
#genetics #ethicsinscience #science
Together they explore:
• How #CRISPR actually works and why unintended mutations matter
• The difference between somatic vs germline editing
• Why nearly all scientists condemned the 2018 CRISPR baby experiment
• Whether population level risks outweigh individual benefits
• Enhancement vs therapy — and why the line is blurry
• What happens when parents can design their children
• Whether existential threats justify genetic engineering
• Why ethicists disagree on whether the action itself is immoral
• Real future scenarios: cheap designer babies, superbugs, AI-powered labs
Chapters:
00:00 – Welcome and Introduction
02:35 – The Heterodox Approach to Disagreement
03:50 – Who Are the Speakers? Bio + Philosophy Backgrounds
06:00 – Why Their Friendship Makes Their Debates Work
07:45 – Proposition: Is Germline Editing Ever Moral?
09:00 – The Science of Gene Editing (CRISPR 101)
13:15 – Real Examples: Mammoths, Dire Wolves, and CRISPR Babies
17:40 – How Embryonic Editing Actually Works
20:55 – Embryonic vs Somatic Editing: Why It Matters
22:40 – Ethical Frameworks for Gene Editing
24:20 – Individual vs Population Level Risks
29:00 – The Problem with Designer Babies
33:40 – Enhancement vs Therapy: A Moving Target
38:20 – Case Study 1: Editing Embryos Today
41:45 – Case Study 2: Safe, Expensive, Therapeutic Editing
47:00 – Case Study 3: Cheap, Unlimited Designer Babies
53:30 – Case Study 4: Extinction Level Threat Scenario
59:30 – Case Study 5: Editing Gametes Instead of Embryos
1:05:10 – Audience Q&A: Therapy vs Enhancement
1:15:00 – Final Predictions for the Next 10 Years
1:18:50 – Closing Thoughts
A Heterodox Conversation™ with Dr. Michael Burns (biologist) and Dr. Joseph Vukov (philosopher) exploring one of the most urgent ethical questions of our time: When — if ever — is it morally permissible to genetically modify human embryos?
Hosted at SUNY Cortland, this session blends hard science with ethical reasoning as Burns and Vukov walk students through the biology of CRISPR, the realities of unintended genetic consequences, the risks of homogenizing the human gene pool, fairness and access, enhancement vs therapy, and the deeper moral questions about human dignity and treating future children as products.
#genetics #ethicsinscience #science
Together they explore:
• How #CRISPR actually works and why unintended mutations matter
• The difference between somatic vs germline editing
• Why nearly all scientists condemned the 2018 CRISPR baby experiment
• Whether population level risks outweigh individual benefits
• Enhancement vs therapy — and why the line is blurry
• What happens when parents can design their children
• Whether existential threats justify genetic engineering
• Why ethicists disagree on whether the action itself is immoral
• Real future scenarios: cheap designer babies, superbugs, AI-powered labs
Chapters:
00:00 – Welcome and Introduction
02:35 – The Heterodox Approach to Disagreement
03:50 – Who Are the Speakers? Bio + Philosophy Backgrounds
06:00 – Why Their Friendship Makes Their Debates Work
07:45 – Proposition: Is Germline Editing Ever Moral?
09:00 – The Science of Gene Editing (CRISPR 101)
13:15 – Real Examples: Mammoths, Dire Wolves, and CRISPR Babies
17:40 – How Embryonic Editing Actually Works
20:55 – Embryonic vs Somatic Editing: Why It Matters
22:40 – Ethical Frameworks for Gene Editing
24:20 – Individual vs Population Level Risks
29:00 – The Problem with Designer Babies
33:40 – Enhancement vs Therapy: A Moving Target
38:20 – Case Study 1: Editing Embryos Today
41:45 – Case Study 2: Safe, Expensive, Therapeutic Editing
47:00 – Case Study 3: Cheap, Unlimited Designer Babies
53:30 – Case Study 4: Extinction Level Threat Scenario
59:30 – Case Study 5: Editing Gametes Instead of Embryos
1:05:10 – Audience Q&A: Therapy vs Enhancement
1:15:00 – Final Predictions for the Next 10 Years
1:18:50 – Closing Thoughts
